Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Avastin Timeline

Avastin Timeline

Avastin timeline
Following the 2002 failure of its Phase III trial of Avastin in previously treated metastatic breast cancer patients, Genentech (DNA) switched focus to first-line use and to an ongoing NCI-funded study. Selected regulatory events for Avastin to treat metastatic breast cancer listed below. Genentech/Roche trials highlighed in brown. Source: FDA briefing documents

Read the full 570 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers